Table 3b. The Panel’s Framework for Assessing the Risk of Progression to Severe COVID-19 Based on Patient Conditions and COVID-19 Vaccination Status
Last Updated: February 29, 2024
Conditions | Risk Level by Vaccination Status | |
---|---|---|
Not Up to Datea,b | Up to Datea | |
Strong or Consistent Association With Progression to Severe COVID-19 | ||
| High | |
| High | Intermediate |
Moderate or Inconsistent Association With Progression to Severe COVID-19 | ||
| Intermediate | |
Weak or Unknown Association With Progression to Severe COVID-19 | ||
| Low |
a See the current COVID-19 vaccination schedule from the CDC.
b Recent SARS-CoV-2 infection (i.e., within 3–6 months) may confer substantial immunity against closely related variants. A patient’s recent infection history should be factored into the risk assessment.
c The degree of risk conferred by obesity in younger children is less clear than it is in older adolescents.
d This includes patients with a tracheostomy and those who require NIV.
e The data for this group are particularly limited.
Key: BMI = body mass index; CDC = Centers for Disease Control and Prevention; NIV = noninvasive ventilation; the Panel = the COVID-19 Treatment Guidelines Panel